Kazuko Kaneda-Nakashima

16PUBLICATIONS
35CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesSolid tumoursAutomotive combustion and fuel engineeringAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies.

|Apr 14, 2026
Flavonoid Interactions with Renal Organic Anion Transporters OAT1 and OAT3: Structure-Activity Relationships and Clinical Implications.

Kai Tong, Pinmao Ye, Kazuko Kaneda-Nakashima

|Nov 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer.

Sifan Feng, Kentaro Hisada, Haruna Yorifuji

|Sep 13, 2025
LAT1-Targeted Alpha Therapy Using 211At-AAMT for Bone and Soft Tissue Sarcomas.

Haruna Takami, Yoshinori Imura, Hidetatsu Outani

|Jun 26, 2025
L-3-[18F]-Fluoro-α-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical Applications.

Mei Bao, Xiang Gu, Kai Tong

|Nov 27, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Kentaro Hisada

Pageof 3

Frequent Collaborators

10 joint publications

Yoshifumi Shirakami

8 joint publications

Tadashi Watabe

8 joint publications

Koichi Fukase

5 joint publications

Kazuhiro Ooe